by Paragraph: Bovine mastitis is an inflammatory reaction in mammary glands of dairy cows caused by bacterial infection. It leads to reduced milk production as well as quality deterioration. Commonly used treatments for bovine mastitis include antibiotics, teat dips, therapeutic formulations, and vaccines. Antibiotics are widely adopted for treatment and prevention of subclinical mastitis. Increasing focus on quality assurance of dairy products is anticipated to drive the demand for mastitis therapeutics and diagnostics.
The global bovine mastitis market is estimated to be valued at US$ 1497.52 Mn in 2024 and is expected to exhibit a CAGR of 9.0% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics:
One of the key drivers for the growth of the bovine mastitis market is the rising demand for high-quality dairy products. Consumers are increasingly demanding dairy products free of antibiotic residues and high nutritional quality. This has necessitated the adoption of advanced therapeutic approaches and diagnostics for effective mastitis management on dairy farms. Proper detection and treatment of mastitis helps ensure safer milk production complying with stringent quality standards.
Another driver is the use of precision livestock farming technologies. Farmers are adopting automation, IoT sensors, and data analytics for real-time monitoring of herd health and diagnosing mastitis on dairy farms. Precision tools facilitate early detection of subclinical mastitis, thereby avoiding economic losses due to severe cases. They enable timely therapeutic intervention and strategies to contain infections on farms. This favors revenue growth of diagnostic products and therapies in the global market.
Segment Analysis
The bovine mastitis market is dominated by the treatment segment which holds around 60% market share. Treatment provides relief from the pain and swelling associated with mastitis in dairy cows. It also protects the quality of milk and prevents the spread of infection to other cows. Antibiotics are commonly prescribed to treat bovine mastitis as they are effective in curing most bacterial infections.
PEST Analysis
Political: Government regulations regarding the use of antibiotics in dairy farming influence the bovine mastitis market. Some nations have imposed restrictions to minimize antibiotic residues in milk.
Economic: Rising demand for dairy products is a key driver for the market. Dairy farmers prioritize cow health to maximize milk production. Mastitis leads to reduced milk yield and increased treatment costs.
Social: Consumer awareness about milk purity and food safety standards impacts treatment practices. Social media highlights animal welfare issues pushing for alternative therapeutic approaches.
Technological: Advancements in diagnostic tests enable rapid and accurate detection of mastitis. Genetic testing helps identify cow breeds resistant to mastitis. Researchers are developing novel therapies to overcome antibiotic resistance.
Key Takeaways
Global Bovine Mastitis Market Size is expected to witness high growth between 2023-2030 backed by the expanding dairy industry worldwide.
Regional analysis:
The Asia Pacific region is anticipated to experience the fastest growth during the forecast period. Growing milk production in China and India presents significant opportunities.
Key players related content comprises: Key players operating in the bovine mastitis market are GE Healthcare, Siemens Healthineers, Philips Healthcare, Cardinal Health, Bayer AG. Several companies are focusing on developing novel antibacterial treatments and rapid diagnostic tests to gain market share.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc.
